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Non-traumatic spinal cord pathology is responsible for 25–52% of all spinal cord lesions. 
Studies have revealed that spinal stenosis accounts for 16–21% of spinal cord injury (SCI) 
admissions. Impaired grips as well as slow unskilled hand and finger movements are the 
most common complaints in patients with spinal cord disorders, such as myelopathy 
secondary to cervical spondylosis. In the past, our team carried out couple of successful 
clinical trials, including two randomized control trials, showing that functional electrical 
stimulation therapy (FEST) can restore voluntary reaching and/or grasping function, 
in people with stroke and traumatic SCI. Motivated by this success, we decided to 
examine changes in the upper limb function following FEST in a patient who suffered 
loss of hand function due to myelopathy secondary to cervical spondylosis. The partici-
pant was a 61-year-old male who had C3–C7 posterior laminectomy and instrumented 
fusion for cervical myelopathy. The participant presented with progressive right hand 
weakness that resulted in his inability to voluntarily open and close the hand and to 
manipulate objects unilaterally with his right hand. The participant was enrolled in the 
study ~22 months following initial surgical intervention. Participant was assessed using 
Toronto Rehabilitation Institute’s Hand Function Test (TRI-HFT), Action Research Arm 
Test (ARAT), Functional Independence Measure (FIM), and Spinal Cord Independence 
Measure (SCIM). The pre–post differences in scores on all measures clearly demon-
strated improvement in voluntary hand function following 15 1-h FEST sessions. The 
changes observed were meaningful and have resulted in substantial improvement in 
performance of activities of daily living. These results provide preliminary evidence that 
FEST has a potential to improve upper limb function in patients with non-traumatic SCI, 
such as myelopathy secondary to cervical spondylosis.
Keywords: functional electrical stimulation, upper extremity rehabilitation, grasping, spinal cord disorders, 
myelopathy
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INtRoDUCtIoN
Although cervical spondylotic myelopathy (CSM) is categorized 
as a degenerative disorder most frequently seen in older indi-
viduals, this type of spinal cord dysfunction is influenced by 
genetic, environmental, and occupational factors as well. Hence, 
CSM affects a spectrum of patients across different age groups 
(1, 2), is the most common cause of spinal cord dysfunction in 
modern society worldwide (3), and is a major source of disability 
(4) that negatively affects quality of life (5, 6). Adults older than 
55 years of age, who have cervical spondylosis are more predis-
posed to CSM as the aging process results in spondylotic changes, 
and these, in turn, result in direct compressive and/or ischemic 
dysfunction of the spinal cord (5, 6). The most characteristic 
CSM syndrome consists of varying combinations of the follow-
ing triad: (a) painful stiff neck, (b) brachialgia and numb hands, 
and (c) spastic leg weakness with unsteadiness of gait (7). Upper 
extremity dysfunction is, in essence, one of the classic sign of 
CSM. This may have a variable presentation in the form of numb-
ness or paresthesia, clumsiness, or weakness of the hand, hand 
and/or forearm muscle weakness, and atrophy, and occasionally 
there may be severe atrophy of the hand muscles. As a result, the 
individuals with CSM syndrome typically experience difficulty 
performing motor tasks, such as buttoning buttons, using keys, 
using a computer keyboard, pushing buttons on a cellular phone, 
or text messaging. These are considered as common early signs 
of CSM (8).
In a prospective study of CSM (8), it was observed that the 
earliest change indicative of CSM was the inability to adduct the 
little finger. This condition further progressed to affect the ring 
and middle fingers. As the disease became more severe, this loss 
of adduction in the fingers innervated by the ulnar nerve was fol-
lowed by the inability to extend them (8). There are many underly-
ing causes for this condition. In most cases, CSM is a progressive 
condition (9). Development of moderate to severe signs and 
symptoms of CSM usually indicate poor prognosis. In those cases 
in which the clinical status and imaging findings corroborate CSM 
diagnosis, surgical intervention may play a key role in managing 
CSM (9). Given the progressive nature of CSM, many clinicians 
advocate surgical treatment of patients with this condition.
In this article, we are presenting a case study in which func-
tional electrical stimulation therapy (FEST) (explained in detail 
in the following section) was applied to an individual who had a 
CSM-related surgical treatment 22 months prior to taking part 
in the study. At the time, the participant enrolled in the study, he 
presented with progressive right hand weakness that resulted in 
his inability to voluntary open and close the hand and manipu-
late objects with his right hand. In what follows, we will present 




Functional electrical stimulation (FES) is a method that is able 
to produce functional movements in paralyzed muscles after an 
injury or damage to the central nervous system, including, but 
not limited to, stroke, spinal cord injury (SCI), and traumatic 
brain injury (10–19). By delivering low energy electrical pulses to 
nerves that are innervating muscles of interest (targeted muscles), 
the FES is able to induce controlled movements in the limbs and 
body (16, 18, 19). Careful application of highly controlled stimu-
lation sequences is able to generate synergistic muscle activations 
that can produce complex movements, such as reaching, grasp-
ing, and walking.
Functional electrical stimulation therapy
Originally, FES was envisioned to be used as an orthotic device 
(also known as neuroprosthesis), intended to be worn perma-
nently with users activating it whenever he/she required to reach 
or grasp an object, or to walk. Our team and others have been 
developing an alternative method for using FES technology. In 
this embodiment, FES technology is used to deliver a short-term 
therapeutic intervention, where the patient is expected to undergo 
a finite number of FEST sessions. Upon completion of the FEST 
program, the patient will have recovered partial or complete volun-
tary motor function in the targeted extremity, i.e., upper or lower 
extremity (20–30). The FEST program is designed to “retrain” the 
injured neuromuscular system, through repetitive performance of 
task-specific exercises. The FES during these training sessions is 
used to provide assistance with the components of the task that 
the individual is unable to perform independently. The assistance 
provided by the FES system to accomplish each task during the 
training session is determined based on day-to-day performance. 
At the completion of the 40–60 1-h-long FEST sessions, the 
individual is usually able to perform the tasks unassisted or with 
minimal assistance (i.e., without the help of FES device).
We have successfully used our FEST program to assist (i) 
adults with incomplete and complete SCI, and (ii) adults and chil-
dren with severe upper limb deficit following stroke, to recover 
sustained reaching and/or grasping motor functions (22, 24, 25, 
27–30). In our upper limb FEST program, the participant must 
attempt to initiate or execute the specific motor task unassisted, 
such as pinch grasp. Once a brief (10- to 20-s long) attempt to per-
form the specific task has been made, the therapist delivers FES-
induced electrical pulses to the muscles to assist the individual to 
complete the task. Multitudes of different reaching and grasping 
tasks are trained. Each task is slightly different, and each task is 
trained on average between 5 and 7 min. During the early stages 
of FEST, performance of the entire task may be supported by FES, 
if required. As the therapy progresses, FES assistance is slowly 
reduced and eventually phased out. We believe that the combina-
tion of (i) active participation of the patient during therapy, (ii) 
the way in which FES system generates the movement, (iii) the 
fidelity of the movement performed using FES, (iv) the accuracy 
with which FES system mimics the natural limb movements, and 
(v) repetitive FES-induced movements are critical ingredients of 
this therapy. Previous experiments in SCI and stroke populations, 
conducted by our team (2, 22–24, 26–28, 30–32) and others (18, 
33–35), indicate that improvements in grasping function, as a 
result of FEST, are meaningful and clinically relevant.
Currently, the mechanisms responsible for recovery of 
function using FEST are unknown. However, few physical 
and neurological mechanisms that may explain the effects of 
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this therapeutic intervention have been already identified. The 
“peripheral” mechanisms are (i) muscle strengthening, (ii) 
increased flexibility and range of motion in the affected limb, and 
(iii) reduced muscle spasticity. The “neurological” mechanisms 
are (i) cortical reorganization, (ii) neuroplastic changes in the 
central nervous system, (iii) strengthening of the synaptic con-
nection via Hebb’s rule, and (iv) functional reorganization and 
retraining of unaffected, but functionally related, areas of the 
central nervous system, allowing them to take control over the 
damaged parts of the central nervous system. Presently, the FEST 
experts are inclined to explain the improvements using the above 
listed and few additional neurological mechanisms (36).
Motivation for this study
In conclusion, there is strong evidence to support the use of FEST 
as an effective tool for retraining of reaching and grasping func-
tions in neurological populations, such as stroke or SCI. Since 
CSM is a degenerative disorder of the cervical spine, which can 
be grouped among non-traumatic SCIs, it is very likely that the 
FEST for reaching and grasping will help this patient population 
improve voluntary reaching and grasping. Furthermore, it has 
been shown that strengthening muscles with the help of FES may 
as well bring about considerable improvements in walking and 
standing functions in the individuals with CSM (37). Therefore, 
this study was conducted to test if similar outcomes can be 
achieved in individuals with CSM following FEST. To the best of 
our knowledge, this is the first reported case of a chronic CSM 
patient treated with FEST for grasping.
DIsCUssIoN
Diagnosis
The study participant was a 61-year-old male who underwent 
C3–C7 posterior laminectomy and instrumented fusion in 
November 2012, for cervical myelopathy. Cervical spine X-ray 
showed degenerative changes more prominent at C4–C7 levels. 
Following surgery, the participant experienced progressive 
weakness in the right hand. In November 2013, he underwent a 
redo cervical decompression and extension of fusion down to T2 
level. Cervical spine MRI revealed moderate foraminal stenosis 
at C5–T1, and it was recommended that he undergoes re-explo-
ration of his previous fusion and extension down to T2, bilateral 
foraminotomies, at C5–C6, C6–C7, and C7–T1. Postoperatively, 
the study participant developed right upper extremity numbness 
and progression of hand weakness. A cervical spine MRI was 
obtained demonstrating no acute findings or evidence of epidural 
hematoma and otherwise expected postoperative findings. The 
numbness and progression of hand weakness were thought to 
be related to intraoperative nerve root manipulation, which are 
typically transient in nature. At 22 months post initial surgery, 
the study participant continued to have right upper extremity 
numbness and weakness of the hand, as well as wasting of the 
intrinsic muscles of the right hand. The participant was unable to 
extend the lateral three fingers, namely, the middle, ring, and little 
fingers, despite relatively well-preserved function of the wrist. He 
was also unable to perform rapid extension of the fingers.
Typically, following the surgery for CSM, one can expect 
significant functional recovery, which should plateau at 6 months 
following the intervention (5, 6). Since the patient did not experi-
ence any significant improvement in hand function at 22-month 
mark, and since his hand function continued to deteriorate, he 
was invited to participate in this FEST case study.
treatment
The patient was screened to confirm that he did not have any con-
traindications (i.e., pacemaker, spinal stimulation, rash or open 
wound at any potential electrode site) to FEST. Prior to participat-
ing in the study, FEST was explained to the patient, including the 
risks and benefits of this treatment. After he received all pertinent 
information, the patient signed an informed consent form that 
was approved by the Research Ethics Board of the Toronto 
Rehabilitation Institute – University Health Network.
Our team has developed a hardware platform that can be used 
to deliver the FEST for improving upper limb function. This 
system is called Compex Motion (38), and it has four current 
regulated stimulation channels. The system can be used to deliver 
customized and diverse reaching and grasping FES protocols. In 
this particular case, the participant received FES protocols that 
enabled him to perform hand opening, palmar grasp, and lateral 
pinch grasp. The stimulation was delivered using standard self-
adhesive surface stimulation electrodes, which were placed on the 
subject’s skin above the following muscles:
•	 flexor digitorum superficialis muscle and the flexor digitorum 
profundus muscle (finger flexion);
•	 flexor pollicis brevis (thumb flexion);
•	 extensor digitorum muscle (finger extension);
•	 lumbrical muscles (finger extension).
Stimulation parameters used to stimulate the above muscles 
were
•	 balanced, biphasic, current regulated electrical pulses;
•	 pulse amplitude from 6 to 30 mA (muscle dependent);
•	 pulse duration from 0 to 250 μs;
•	 pulse frequency 40 Hz.
The stimulation sequences (protocols) for this patient were 
tailored to his clinical presentation and his goals of therapy. 
The protocols allowed the participant to grasp and manipulate 
objects with the help of FES delivered by the Compex Motion 
system. The command for activating the stimulation sequence 
was initiated by a pushbutton that was triggered by the therapist 
who administered the therapy. Typical activation process was as 
follows. The participant was instructed on a particular grasping 
or hand opening task that he was supposed to perform. Then, the 
therapist instructed the participant to try to perform that task. 
The participant was given 10–20 s to try to execute the task on 
his own. Only after the participant completed as much of the task 
as he could by himself, the FES was triggered by the therapist 
to assist the participant in completing the entire task/movement. 
The participant received FEST three times per week for 5 weeks, 
i.e., 15 treatments sessions in total.
The subject was trained to perform (i) hand opening using 
finger extensors only, (ii) hand opening using a combination of 
FIGURe 1 | tRI Hand Function test – object manipulation. (a–C) Object manipulation before FES therapy, i.e., patient unable to grasp and manipulate objects, 
and (D–F) Object manipulation after FES therapy, i.e., patient able to grasp and manipulate objects.
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lumbrical muscles and finger extensors, (iii) palmar grasp, and 
(iv) lateral pinch grasp. Throughout FEST sessions, the participant 
was taught how to approach, reach, grasp, and manipulate various 
objects without a fear that he will drop them during the object 
manipulation process. The FES-assisted grasping ensured that all 
objects were grasped robustly and could be manipulated with ease. 
With time, this training allowed the participant to become more 
confident in reaching, grasping, and manipulating objects. As a 
result, with time, the participant started to perform the same reach-
ing, grasping, and object manipulation tasks, without using FES.
outcome Measures
At baseline and following completion of 15 FEST sessions, the 
participant was assessed using the following standardized assess-
ments. The assessments were performed by a researcher who was 
not involved in the therapy delivery process.
Toronto Rehabilitation Institute’s Hand Function Test
Toronto Rehabilitation Institute’s Hand Function Test (TRI-HFT) 
(39) was used to assess unilateral gross motor function of the 
hand. The TRI-HFT consists of two sub-tests. The first one evalu-
ates object manipulation skills using palmar grasp and lateral or 
pulp pinch grasp, and the second one evaluates the strength of 
both palmar and lateral pinch grasps. Note: TRI-HFT has been 
found to be very responsive to FEST.
Action Research Arm Test
Action Research Arm Test (ARAT) (40, 41) is a test developed to 
assess the upper limb function in stroke patients, and it consists of 
four sub-tests: grasp, grip, pinch, and gross movement.
Functional Independence Measure
Functional Independence Measure (FIM) (42) is an assessment 
specially developed to measure the degree of independence. The 
FIM is commonly used by both rehabilitation institutions and 
insurance companies to monitor patients’ improvements during 
rehabilitation.
Spinal Cord Independence Measure
Spinal Cord Independence Measure (SCIM) (43) is a disability 
scale that has been specifically developed to evaluate the functional 
outcomes of patients with traumatic and non-traumatic SCI.
ResULts
The participant completed 15 therapy sessions, as well as baseline 
and discharge assessments. Following 5 weeks of FEST, the par-
ticipant was able to pick up small objects, which he was unable 
to do prior to FEST (see Figure 1). Table 1 summarizes all the 
clinical assessment scores at baseline and at discharge (i.e., after 
completion of therapy).





•	 ARAT – total score (MCID = 5.7) 37 44 7a
•	 ARAT – grasp 13 17 4
•	 ARAT – grip 10 10 0
•	 ARAT – pinch 5 8 3
•	 ARAT – gross movement 9 9 0
tRI-HFt
•	 TRI-HFT – object manipulation (MCID 
not available)
54 65 11a
•	 TRI-HFT – wooden blocks (MCID not 
available)
48 62 14a
•	 TRI-HFT – instrumented cylinder (Nm) 0.2 0.5 0.3
•	 TRI-HFT – credit card (N) 0 5 5
•	 TRI-HFT – wooden bar thumb direction 3 10 7




•	 FIM – total score (MCID = 22) 109 119 10




•	 SCIM – total score (MCID not available) 92 95 3
•	 SCIM – self-care sub-score (MCID not 
available)
12 15 3
ARAT, Action Research Arm Test; TRI-HFT, Toronto Rehabilitation Institute’s 
Hand Function Test; FIM, Functional Independence Measure; SCIM, Spinal Cord 
Independence Measure; MCID, minimum clinically important difference.
aChange scores represent clinically meaningful change.
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This case study examined the efficacy of FEST as a clinical 
intervention for treating severe upper extremity impairment due 
to myelopathy secondary to cervical spondylosis. We found that 
the participant experienced considerable and clinically meaning-
ful improvements in hand function as measured by TRI-HFT 
and ARAT. The pre/post differences in scores on all measures 
clearly demonstrated improvement in voluntary hand function 
following FEST. It is noteworthy that, in subacute stroke and 
traumatic SCI individuals, at least 20 and preferably 40 1-h FEST 
sessions are required to achieve clinically meaningful change. The 
fact that we were able to elicit clinically meaningful change in a 
chronic patient with CSM after only 15 1-h sessions suggests that 
the FEST for upper limb may be a viable therapeutic intervention 
for this patient population. These results provide preliminary evi-
dence that rehabilitation treatment consisting of repetitive FEST 
designed to improve arm and hand function has the potential to 
restore voluntary grasping function in patients with CSM. The 
results also suggest that FEST leads to subsequent improvements 
in the quality and complexity of tasks that the participant was able 
to execute before and after study completion. These improvements 
in hand function subsequently lead to improvements in activities 
of daily living and increased level of independence. Following 
therapy completion, the participant subjectively reported (i) that 
he has observed improvements in his arm and hand function, and 
that he felt that he gained additional independence in activities of 
daily living; (ii) that the FEST allowed him to “awake his hand” 
when his fingers felt “dead” and “glued together”; (iii) that he 
experienced “more normal” movements in his hand and greater 
articulation in his fingers especially with respect to fine motor 
skills; and (iv) that he is now functioning at a “higher level.”
CoNCLUDING ReMaRKs
The results of our study are very encouraging; however, the study 
has certain limitations. This is a single case study with no control 
group, which makes it difficult to comment on comparative 
improvement that could have been achieved if the participant 
was administered a same dose of conventional occupational 
therapy alone. However, we have to acknowledge that the 
participant decided to participate in this study because he had 
already reached a plateau in recovery following many sessions 
of conventional occupational therapy. Based on the results of 
this case study, we believe that a study with a larger number of 
CSM patients is warranted, where the effects of FEST for reaching 
and grasping can be compared against current best practices for 
 treating this patient population.
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